FDA to launch advisory committee on digital health technologies
The Food and Drug Administration will accept nominations through Dec. 11 for experts to serve on a committee that will advise the agency on issues related to digital health technologies, from artificial intelligence/machine learning and digital therapeutics to wearables and remote patient monitoring.
“Many of these technologies are novel and tend to rapidly change; it’s our duty to seek as much knowledge on them as possible as we determine and implement appropriate regulation to encourage innovation while protecting public health,” said Troy Tazbaz, director of the FDA’s Digital Health Center of Excellence.
Related News Articles
Headline
The Cybersecurity and Infrastructure Security Agency Dec. 11 released an update to its voluntary Cybersecurity Performance Goals, which includes measurable…
Headline
U.S. and international agencies are warning of potential cyberattacks on health care and other critical infrastructure from state-sponsored cyber actors in…
Headline
A critical, unauthenticated remote code execution vulnerability known as React2Shell has been added to the Cybersecurity and Infrastructure Security Agency’s…
Headline
The Department of Health and Human Services Dec. 4 released its strategy on integrating artificial intelligence across internal operations, research and public…
Headline
The FBI has public resources available to help prevent exploitation by cybercriminals, who use artificial intelligence for deception. An infographic by the FBI…
Headline
A critical vulnerability has been identified in 7-Zip, a free software program used for archiving data, according to the National Institute of Standards and…